Website
Business Details
Digital Mental Health Solutions for Insomnia & Anxiety
Big Health was founded on the principle that effective mental healthcare should be accessible to all. Our journey began when co-founder Peter Hames struggled with insomnia and discovered the transformative potential of cognitive behavioral therapy (CBT) through the work of Dr. Colin Espie. Recognizing that millions could benefit from this approach, we developed digital solutions to scale evidence-based care. Our team combines clinical expertise with innovative design and technology to address insomnia, anxiety, and mood disorders. With over 100 peer-reviewed publications and 22 randomized controlled trials validating our methods, we provide FDA-cleared digital therapeutics trusted by health systems, employers, and providers. Our solutions reduce waitlists, improve outcomes, and lower costs while maintaining rigorous clinical standards.

Backed by industry-leading research and partnerships with institutions like UCSF and Accolade, we prioritize patient-centric care that adapts to individual needs. Our commitment to quality is reflected in our clinical validation, regulatory approvals, and recognition by leading authorities in digital health. We work collaboratively with payers, practitioners, and policymakers to expand access to mental health care, ensuring our solutions align with the latest clinical guidelines and patient needs. Through continuous innovation and adherence to ethical standards, we strive to redefine the future of mental healthcare delivery.
Services
Digital CBT for Insomnia Anxiety Treatment FDA-Cleared Therapeutics Mental Health Solutions Digital Therapeutics
Highlights and features
  • We offer evidence-based cognitive behavioral therapy validated by 100+ peer-reviewed studies.
  • Our FDA-cleared digital therapeutics provide instant access to care without waitlists.
  • We combine clinical expertise with technology to deliver scalable mental health solutions.
  • Our treatments demonstrate 76% clinical improvement in insomnia and 71% in anxiety.
  • We partner with health systems to expand access to first-line mental healthcare.
Associations and certifications
  • FDA
What people say
Improved my sleep More in control More self-aware Helped my anxiety Feel more joy
Services
Digital CBT for Insomnia
Our digital cognitive behavioral therapy for insomnia combines interactive video lessons, personalized sleep tracking, and behavioral techniques to address chronic sleep issues. The program adapts to individual patient needs while maintaining clinical rigor, with proven results showing 76% of users achieve clinical improvement. Backed by 26 clinical trials and FDA clearance, this treatment offers an alternative to medication without serious side effects.
Anxiety Treatment
Our anxiety treatment utilizes evidence-based cognitive restructuring techniques and behavioral interventions to address generalized anxiety disorder. The program delivers structured therapy through mobile applications with demonstrated 71% clinical remission rates. As an FDA-cleared therapeutic, it provides non-pharmacological treatment options supported by randomized controlled trials and clinical implementation satisfaction scores exceeding 9.8/10.
Digital Therapeutics
We develop prescription digital therapeutics for mental health conditions including insomnia, anxiety, and mood disorders. These FDA-cleared applications deliver cognitive behavioral therapy through engaging multimedia content while maintaining clinical validation through 22 completed randomized controlled trials. Our solutions integrate with existing care models to expand treatment capacity and improve patient outcomes.
Questions
What FDA-cleared treatments does Big Health offer?
We provide SleepioRx for insomnia and DaylightRx for generalized anxiety disorder, both delivering evidence-based cognitive behavioral therapy through mobile applications.
How do clinicians order your digital therapeutics?
Providers can order treatments through our secure platform by entering patient details and distributing unique access codes via text message.
What clinical evidence supports your solutions?
Our treatments have undergone 26 clinical trials, including 18 randomized controlled trials demonstrating 76% improvement in insomnia and 71% in anxiety outcomes.
Which insurers cover your digital treatments?
CMS has established reimbursement codes for Medicare coverage effective January 2025, with ongoing expansion into commercial payer networks.
What mental health conditions do you treat?
We address chronic insomnia, generalized anxiety disorder, and major depressive disorder through digital cognitive behavioral therapy programs.
How do your solutions integrate with existing care models?
Our therapeutics serve as first-line treatments, waitlist support, therapy reinforcement, and maintenance tools within comprehensive mental health care plans.